BioLineRx (BLRX) Return on Assets [ROA] (2013 - 2026)
BioLineRx's Return on Assets [ROA] came in at -31.03% for the quarter ended Jun 30, 2026, down 11.32 percentage points from -19.71% a year earlier and down 3.89 percentage points from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, BioLineRx's Return on Assets [ROA] was -5.08%, up 12.86 percentage points from the prior year.
- Return on Assets [ROA] carries a five-year change of +54.45 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, Return on Assets [ROA] was -17.93% in the year ended Dec 31, 2024 (+68.47 pp), -86.40% in the year ended Dec 31, 2023 (-54.77 pp), -31.63% in the year ended Dec 31, 2022 (+10.42 pp) and -42.05% in the year ended Dec 31, 2021 (+17.48 pp).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Return on Assets [ROA] since the quarter ended Sep 30, 2024.
- Year-over-year, Return on Assets [ROA] has declined for three consecutive quarters, with an average year-over-year change of +28.58 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in the quarter ended Dec 31, 2024 (a gain of 96.97 percentage points), and the weakest in the quarter ended Dec 31, 2023 (a drop of 71.31 percentage points).
- Business Quant data shows BLRX's Return on Assets [ROA] at -27.14% (quarter ended Mar 31, 2026), -24.65% (quarter ended Dec 31, 2025) and -16.26% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | -31.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.03% |
| Mar 31, 2026 | -27.14% |
| Dec 31, 2025 | -24.65% |
| Sep 30, 2025 | -16.26% |
| Jun 30, 2025 | -19.71% |
| Mar 31, 2025 | -10.02% |
| Dec 31, 2024 | -6.87% |
| Sep 30, 2024 | -37.94% |
| Jun 30, 2024 | -51.88% |
| Mar 31, 2024 | -85.12% |
| Dec 31, 2023 | -103.84% |
| Sep 30, 2023 | -86.86% |
| Jun 30, 2023 | -69.04% |
| Mar 31, 2023 | -45.43% |
| Dec 31, 2022 | -32.53% |
| Sep 30, 2022 | -31.27% |
| Jun 30, 2022 | -31.40% |
| Mar 31, 2022 | -27.91% |
| Dec 31, 2021 | -32.15% |
| Sep 30, 2021 | -38.98% |
API Access
BioLineRx Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();